Cytapheresis of Volunteer Donors
NCT00104325 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2026-05-29
Summary
Background:
\- National Institute on Aging researchers are looking at studies that require large numbers of white blood cells for lab use. Standard blood samples do not provide enough white blood cells for these studies. Researchers want to use cytapheresis to collect white blood cells from volunteer donors. This procedure can collect larger amounts of white blood cells and reduce the amount of fluid and other cells that are lost.
Objectives:
\- To use cytapheresis to collect white blood cells for study.
Eligibility:
\- Healthy blood donors at least 18 years of age.
Design:
* Participants will be screened according to the usual blood donation procedures.
* Participants will provide white blood cells through cytapheresis. The blood cells will be collected in a machine that separates the white blood cells from the rest of the blood. The rest of the blood will be returned to the donor.
* Participants may have this type of donation every 56 days (six times per year). They will be asked to become a repeat donor. A donation schedule may be set up.
* Once a year, participants will have blood tests to continue to be eligible as a donor.
Conditions
- Healthy Volunteers
Sponsors & Collaborators
-
National Institute on Aging (NIA)
lead NIH
Principal Investigators
-
Chee W Chia, M.D. · National Institute on Aging (NIA)
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-01-30
Countries
- United States
Study Locations
More Related Trials
-
The Internal Thoracic Artery Skeletonization Study: A Paired, Within-Patient Comparison
NCT00265499 ·Status: COMPLETED ·Phase: NA
-
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
NCT02566525 ·Status: COMPLETED ·Phase: NA
-
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
NCT00879268 ·Status: COMPLETED ·Phase: PHASE1
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
NCT03204357 ·Status: RECRUITING ·Phase: NA
-
Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients
NCT05889494 ·Status: COMPLETED ·Phase: NA
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
NCT05189262 ·Status: RECRUITING
-
Mini Versus Conventional Cardiopulmonary Bypass In CABG in Asian Patients
NCT03657225 ·Status: COMPLETED ·Phase: NA
-
The Use of HEMOBAG to Salvage Blood After Cardiac Surgery
NCT00176657 ·Status: TERMINATED ·Phase: PHASE2
-
Endothelial Progenitor Cells
NCT01686269 ·Status: UNKNOWN ·Phase: NA
-
Cell Savers and Blood Quality
NCT02046824 ·Status: TERMINATED ·Phase: NA
-
Predicting Fluid Responsiveness in on Pump Coronary Artery Bypass Graft Using Extra Systoles
NCT02903316 ·Status: COMPLETED
-
Transfusion Triggers in Cardiac Surgery
NCT00470444 ·Status: COMPLETED ·Phase: NA
-
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
NCT01540422 ·Status: COMPLETED
-
Blood Conservation in Adult Cardiac Surgery, What is the Way Forward in Today's Practice?
NCT02595385 ·Status: UNKNOWN ·Phase: NA
-
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
NCT01313533 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study on CRP Apheresis After Coronary Bypass Surgery
NCT04745468 ·Status: COMPLETED ·Phase: NA
-
Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function
NCT01469676 ·Status: COMPLETED ·Phase: NA
-
A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume
NCT00816023 ·Status: COMPLETED ·Phase: PHASE2
-
Endoscopic Vessel Harvesting During Coronary Bypass Surgery
NCT00235846 ·Status: COMPLETED ·Phase: NA
-
Haemoadsorption During Heart Transplantation
NCT05270902 ·Status: RECRUITING ·Phase: NA
-
Cytokine Clearance With Cytoabsorbant Device During Cardiac Bypass
NCT02775123 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
NCT03326323 ·Status: COMPLETED
-
Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
NCT01083914 ·Status: COMPLETED
-
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)
NCT00107666 ·Status: TERMINATED ·Phase: PHASE2
-
Lung Perfusion With Oxygenated Blood During Aortic Clamping
NCT01186510 ·Status: COMPLETED ·Phase: NA